Zomedica Corp. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zomedica Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Zomedica Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.44M, a 25.1% decline year-over-year.
  • Zomedica Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$30.2M, a 19.2% decline year-over-year.
  • Zomedica Corp. annual Operating Income (Loss) for 2023 was -$7.51M, a 65.7% increase from 2022.
  • Zomedica Corp. annual Operating Income (Loss) for 2022 was -$21.9M, a 2.57% decline from 2021.
  • Zomedica Corp. annual Operating Income (Loss) for 2021 was -$21.4M, a 27.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.